ORION Holdings Corp. Stock price

Equities

A001800

KR7001800002

Food Processing

End-of-day quote Korea S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
14,210 KRW -0.14% Intraday chart for ORION Holdings Corp. +0.71% -2.67%
Sales 2022 2,935B 2.18B Sales 2023 2,954B 2.19B Capitalization 878B 652M
Net income 2022 103B 76.4M Net income 2023 85.62B 63.53M EV / Sales 2022 0.03 x
Net cash position 2022 823B 610M Net cash position 2023 1,033B 766M EV / Sales 2023 -0.05 x
P/E ratio 2022
8.97 x
P/E ratio 2023
10.3 x
Employees 8
Yield 2022
4.56%
Yield 2023
5.14%
Free-Float 32.18%
More Fundamentals * Assessed data
Dynamic Chart
ORION Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ORION Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Eion Corp announced that it has received $13.064976 million in funding from a group of investors CI
Eion Corp announces tranche update CI
Eion Corp announced that it expects to receive funding from a group of investors CI
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Transcript : Orion Group Holdings, Inc., Q4 2021 Earnings Call, Mar 03, 2022
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp. CI
Genomictree Inc. announced that it expects to receive KRW 5.00000105 billion in funding from ORION Holdings Corp. CI
Shandong Lukang Biotechnology Development Co., Ltd. announced that it has received CNY 195 million in funding from Shandong Lukang Pharmaceutical Co.,Ltd., Orion Food Co., Ltd., ORION Holdings Corp. CI
More news
1 day-0.14%
1 week+0.71%
Current month-0.63%
1 month-2.40%
3 months-3.99%
6 months-7.00%
Current year-2.67%
More quotes
1 week
14 110.00
Extreme 14110
14 520.00
1 month
14 070.00
Extreme 14070
15 160.00
Current year
13 090.00
Extreme 13090
15 440.00
1 year
13 090.00
Extreme 13090
17 440.00
3 years
13 090.00
Extreme 13090
18 750.00
5 years
10 400.00
Extreme 10400
20 850.00
10 years
10 400.00
Extreme 10400
404 931.33
More quotes
Managers TitleAgeSince
Director/Board Member 60 15-01-31
Director/Board Member 64 14-06-30
Corporate Officer/Principal 68 75-01-31
Members of the board TitleAgeSince
Corporate Officer/Principal 68 80-03-31
Corporate Officer/Principal 68 75-01-31
Director/Board Member 64 14-06-30
More insiders
Date Price Change Volume
24-03-27 14,210 -0.14% 37,484
24-03-26 14,230 0.00% 42,200
24-03-25 14,230 -0.91% 41,604
24-03-22 14,360 -0.62% 27,932
24-03-21 14,450 +2.41% 60,086

End-of-day quote Korea S.E., March 26, 2024

More quotes
ORION Corp. is a Korea-based company mainly engaged in the production and sale of biscuits and snacks. Along with subsidiaries, the Company operates its business through two segments. The Food and Beverage Manufacturing segment is involved in the production and sale of biscuits, pies, gums, chocolates, chocolate pies and snacks. The main products are made under the name of Chocochip Choco Pie, Choco Pie Banana, Oh! Gamja, Dodohan Nacho, Tonk, Choco Boy,The Xylitol VitaC, Hotbreak. The Other segment is involved in the production, distribution and sale of films, as well as construction business. The Company distributes its products within the domestic market and to overseas markets, including China, Vietnam and Russia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock
  2. Equities
  3. Stock ORION Holdings Corp. - Korea S.E.